Pot sector falls into correction territory, but MedMen jumps after $682 million acquisition

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

A key tracker of the marijuana industry has fallen into correction territory -- but there's still one pot stock that's a bright spot today.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

Igc

CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 3. in EG

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Marijuana stocks to watch: MedMen turns a vision into reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality. Ticker isn’t on robinhood?
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyMedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date. ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »

Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

'Retail is the place to be' in cannabis, says MedMen CEO after 'blockbuster' PharmaCann acquisitionJim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »

The CEO of the biggest cannabis company in the US reveals his strategy for defending against multi-billion private equity fundsBI PRIME: Hot off of a $682 million acquisition, Adam Bierman, the CEO of MedMen — now the biggest cannabis company in the US — opens up about who his biggest competition is and how he's defending against them.
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »

A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisitionBI PRIME: iAnthus, a multistate cannabis dispensary operator, acquired Toronto-based MPX Bioceutical in a $640 million all-stock transaction. The deal comes on the heels of rival MedMen's $682 million acquisition of PharmaCann. BIPrime Are they considering a 'joint' venture?
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »

Cannabis industry shops for a suit and tieMoney is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
مصدر: Breakingviews - 🏆 470. / 51 اقرأ أكثر »

High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyMedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date. ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »